Table of Content

1 Ofatumumab Market Overview
1.1 Product Overview and Scope of Ofatumumab
1.2 Ofatumumab Segment by Type
1.2.1 Global Ofatumumab Market Value Comparison by Type (2024-2034)
1.2.2 20mg/1mL
1.2.3 20mg/0.4mL
1.2.4 100mg/5mL
1.2.5 Others
1.3 Ofatumumab Segment by Application
1.3.1 Global Ofatumumab Market Value by Application: (2024-2034)
1.3.2 Relapsing-remitting Multiple Sclerosis
1.3.3 Clinically Isolated Syndrome
1.3.4 Active Secondary Progressive Multiple Sclerosis
1.3.5 Others
1.4 Global Ofatumumab Market Size Estimates and Forecasts
1.4.1 Global Ofatumumab Revenue 2018-2034
1.4.2 Global Ofatumumab Sales 2018-2034
1.4.3 Global Ofatumumab Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Ofatumumab Market Competition by Manufacturers
2.1 Global Ofatumumab Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ofatumumab Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ofatumumab Average Price by Manufacturers (2018-2023)
2.4 Global Ofatumumab Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Ofatumumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ofatumumab, Product Type & Application
2.7 Ofatumumab Market Competitive Situation and Trends
2.7.1 Ofatumumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ofatumumab Players Market Share by Revenue
2.7.3 Global Ofatumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ofatumumab Retrospective Market Scenario by Region
3.1 Global Ofatumumab Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Ofatumumab Global Ofatumumab Sales by Region: 2018-2034
3.2.1 Global Ofatumumab Sales by Region: 2018-2023
3.2.2 Global Ofatumumab Sales by Region: 2024-2034
3.3 Global Ofatumumab Global Ofatumumab Revenue by Region: 2018-2034
3.3.1 Global Ofatumumab Revenue by Region: 2018-2023
3.3.2 Global Ofatumumab Revenue by Region: 2024-2034
3.4 North America Ofatumumab Market Facts & Figures by Country
3.4.1 North America Ofatumumab Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Ofatumumab Sales by Country (2018-2034)
3.4.3 North America Ofatumumab Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ofatumumab Market Facts & Figures by Country
3.5.1 Europe Ofatumumab Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Ofatumumab Sales by Country (2018-2034)
3.5.3 Europe Ofatumumab Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ofatumumab Market Facts & Figures by Country
3.6.1 Asia Pacific Ofatumumab Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Ofatumumab Sales by Country (2018-2034)
3.6.3 Asia Pacific Ofatumumab Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ofatumumab Market Facts & Figures by Country
3.7.1 Latin America Ofatumumab Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Ofatumumab Sales by Country (2018-2034)
3.7.3 Latin America Ofatumumab Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ofatumumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Ofatumumab Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Ofatumumab Sales by Country (2018-2034)
3.8.3 Middle East and Africa Ofatumumab Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ofatumumab Sales by Type (2018-2034)
4.1.1 Global Ofatumumab Sales by Type (2018-2023)
4.1.2 Global Ofatumumab Sales by Type (2024-2034)
4.1.3 Global Ofatumumab Sales Market Share by Type (2018-2034)
4.2 Global Ofatumumab Revenue by Type (2018-2034)
4.2.1 Global Ofatumumab Revenue by Type (2018-2023)
4.2.2 Global Ofatumumab Revenue by Type (2024-2034)
4.2.3 Global Ofatumumab Revenue Market Share by Type (2018-2034)
4.3 Global Ofatumumab Price by Type (2018-2034)
5 Segment by Application
5.1 Global Ofatumumab Sales by Application (2018-2034)
5.1.1 Global Ofatumumab Sales by Application (2018-2023)
5.1.2 Global Ofatumumab Sales by Application (2024-2034)
5.1.3 Global Ofatumumab Sales Market Share by Application (2018-2034)
5.2 Global Ofatumumab Revenue by Application (2018-2034)
5.2.1 Global Ofatumumab Revenue by Application (2018-2023)
5.2.2 Global Ofatumumab Revenue by Application (2024-2034)
5.2.3 Global Ofatumumab Revenue Market Share by Application (2018-2034)
5.3 Global Ofatumumab Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Glaxosmithkline Inc
6.1.1 Glaxosmithkline Inc Corporation Information
6.1.2 Glaxosmithkline Inc Description and Business Overview
6.1.3 Glaxosmithkline Inc Ofatumumab Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Glaxosmithkline Inc Ofatumumab Product Portfolio
6.1.5 Glaxosmithkline Inc Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Ofatumumab Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Ofatumumab Product Portfolio
6.2.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ofatumumab Industry Chain Analysis
7.2 Ofatumumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ofatumumab Production Mode & Process
7.4 Ofatumumab Sales and Marketing
7.4.1 Ofatumumab Sales Channels
7.4.2 Ofatumumab Distributors
7.5 Ofatumumab Customers
8 Ofatumumab Market Dynamics
8.1 Ofatumumab Industry Trends
8.2 Ofatumumab Market Drivers
8.3 Ofatumumab Market Challenges
8.4 Ofatumumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ofatumumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ofatumumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ofatumumab Market Competitive Situation by Manufacturers in 2024
Table 4. Global Ofatumumab Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Ofatumumab Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Ofatumumab Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Ofatumumab Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Ofatumumab Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Ofatumumab, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Ofatumumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ofatumumab, Product Type & Application
Table 12. Global Key Manufacturers of Ofatumumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ofatumumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ofatumumab as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ofatumumab Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Ofatumumab Sales by Region (2018-2023) & (K Units)
Table 18. Global Ofatumumab Sales Market Share by Region (2018-2023)
Table 19. Global Ofatumumab Sales by Region (2024-2034) & (K Units)
Table 20. Global Ofatumumab Sales Market Share by Region (2024-2034)
Table 21. Global Ofatumumab Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Ofatumumab Revenue Market Share by Region (2018-2023)
Table 23. Global Ofatumumab Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Ofatumumab Revenue Market Share by Region (2024-2034)
Table 25. North America Ofatumumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Ofatumumab Sales by Country (2018-2023) & (K Units)
Table 27. North America Ofatumumab Sales by Country (2024-2034) & (K Units)
Table 28. North America Ofatumumab Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Ofatumumab Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Ofatumumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Ofatumumab Sales by Country (2018-2023) & (K Units)
Table 32. Europe Ofatumumab Sales by Country (2024-2034) & (K Units)
Table 33. Europe Ofatumumab Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Ofatumumab Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Ofatumumab Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Ofatumumab Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Ofatumumab Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Ofatumumab Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Ofatumumab Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Ofatumumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Ofatumumab Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Ofatumumab Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Ofatumumab Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Ofatumumab Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Ofatumumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Ofatumumab Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Ofatumumab Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Ofatumumab Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Ofatumumab Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Ofatumumab Sales (K Units) by Type (2018-2023)
Table 51. Global Ofatumumab Sales (K Units) by Type (2024-2034)
Table 52. Global Ofatumumab Sales Market Share by Type (2018-2023)
Table 53. Global Ofatumumab Sales Market Share by Type (2024-2034)
Table 54. Global Ofatumumab Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Ofatumumab Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Ofatumumab Revenue Market Share by Type (2018-2023)
Table 57. Global Ofatumumab Revenue Market Share by Type (2024-2034)
Table 58. Global Ofatumumab Price (US$/Unit) by Type (2018-2023)
Table 59. Global Ofatumumab Price (US$/Unit) by Type (2024-2034)
Table 60. Global Ofatumumab Sales (K Units) by Application (2018-2023)
Table 61. Global Ofatumumab Sales (K Units) by Application (2024-2034)
Table 62. Global Ofatumumab Sales Market Share by Application (2018-2023)
Table 63. Global Ofatumumab Sales Market Share by Application (2024-2034)
Table 64. Global Ofatumumab Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Ofatumumab Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Ofatumumab Revenue Market Share by Application (2018-2023)
Table 67. Global Ofatumumab Revenue Market Share by Application (2024-2034)
Table 68. Global Ofatumumab Price (US$/Unit) by Application (2018-2023)
Table 69. Global Ofatumumab Price (US$/Unit) by Application (2024-2034)
Table 70. Glaxosmithkline Inc Corporation Information
Table 71. Glaxosmithkline Inc Description and Business Overview
Table 72. Glaxosmithkline Inc Ofatumumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Glaxosmithkline Inc Ofatumumab Product
Table 74. Glaxosmithkline Inc Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Ofatumumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novartis Ofatumumab Product
Table 79. Novartis Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Ofatumumab Distributors List
Table 83. Ofatumumab Customers List
Table 84. Ofatumumab Market Trends
Table 85. Ofatumumab Market Drivers
Table 86. Ofatumumab Market Challenges
Table 87. Ofatumumab Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ofatumumab
Figure 2. Global Ofatumumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ofatumumab Market Share by Type in 2024 & 2034
Figure 4. 20mg/1mL Product Picture
Figure 5. 20mg/0.4mL Product Picture
Figure 6. 100mg/5mL Product Picture
Figure 7. Others Product Picture
Figure 8. Global Ofatumumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Ofatumumab Market Share by Application in 2024 & 2034
Figure 10. Relapsing-remitting Multiple Sclerosis
Figure 11. Clinically Isolated Syndrome
Figure 12. Active Secondary Progressive Multiple Sclerosis
Figure 13. Others
Figure 14. Global Ofatumumab Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Ofatumumab Market Size (2018-2034) & (US$ Million)
Figure 16. Global Ofatumumab Sales (2018-2034) & (K Units)
Figure 17. Global Ofatumumab Average Price (US$/Unit) & (2018-2034)
Figure 18. Ofatumumab Report Years Considered
Figure 19. Ofatumumab Sales Share by Manufacturers in 2024
Figure 20. Global Ofatumumab Revenue Share by Manufacturers in 2024
Figure 21. The Global 5 and 10 Largest Ofatumumab Players: Market Share by Revenue in 2024
Figure 22. Ofatumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 23. Global Ofatumumab Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 24. North America Ofatumumab Sales Market Share by Country (2018-2034)
Figure 25. North America Ofatumumab Revenue Market Share by Country (2018-2034)
Figure 26. United States Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Ofatumumab Sales Market Share by Country (2018-2034)
Figure 29. Europe Ofatumumab Revenue Market Share by Country (2018-2034)
Figure 30. Germany Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Ofatumumab Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Ofatumumab Revenue Market Share by Region (2018-2034)
Figure 37. China Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Taiwan Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Southeast Asia Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Ofatumumab Sales Market Share by Country (2018-2034)
Figure 45. Latin America Ofatumumab Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Ofatumumab Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Ofatumumab Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Ofatumumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Ofatumumab by Type (2018-2034)
Figure 55. Global Revenue Market Share of Ofatumumab by Type (2018-2034)
Figure 56. Global Ofatumumab Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Ofatumumab by Application (2018-2034)
Figure 58. Global Revenue Market Share of Ofatumumab by Application (2018-2034)
Figure 59. Global Ofatumumab Price (US$/Unit) by Application (2018-2034)
Figure 60. Ofatumumab Value Chain
Figure 61. Ofatumumab Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed